Filtered Listing Testing
BrightFocus Foundation today lauded a new, innovative citizen science project, EyesOnALZ, which recently launched an online game - Stall Catchers - to engage the public in helping researchers analyze Alzheimer’s data in the hopes of more quickly discovering ways to prevent and treat the disease.
The fall 2016 edition of the National Glaucoma Research Report explores a study examining the effects of pressure fluctuations on glaucoma that may lead to new treatment approaches, explains why a dilated eye exam is a must, provides vision tips for winter driving, and more.
Kristine Yaffe, MD, a former BrightFocus grantee and expert on modifiable Alzheimer’s risk factors, answers questions about how to lower your risk of dementia.
More and more people are paying attention to lifestyle changes aimed at keeping the brain healthy, and helping to keep Alzheimer’s at bay. Not a total solution, but one that could help.
Learn about a link between wet and dry macular degeneration and cataracts; a quiz to test your knowledge of macular degeneration; information that you need to know the dry form of this eye disease, and more in the summer edition of macular degeneration newsletter.
BrightFocus Foundation, Geoffrey Beene Foundation Alzheimer’s Initiative, AnthroTronix, and Mindoula, have launched Phase II of the Health-eBrain Study, investigating the impact the Alzheimer’s caregiving experience has on brain and behavioral health.
BrightFocus-funded research, along with our national and international connections, are on display at major Alzheimer’s conference.
BrightFocus Foundation joins the nation in mourning the death of Pat Summitt, the winningest college basketball coach of all time.
Learn about a new concept for restoring sight to damaged eyes, how researchers are turning a patients’ own cells into retinal ganglion cells, a discussion regarding the medical vs. surgical treatment of glaucoma, and more in the summer edition of our glaucoma newsletter.
BrightFocus event recognizes top scientists and advocates in Alzheimer's and vision disease.